Anzeige
Mehr »
Samstag, 15.11.2025 - Börsentäglich über 12.000 News
Trump. Zölle. Craig Parry. Vizsla Copper wird zur strategisch wichtigsten Kupferaktie Nordamerikas
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YC53 | ISIN: AU000000AYN6 | Ticker-Symbol: N/A
1-Jahres-Chart  (nicht börsennotiert)
ALCYONE RESOURCES LTD Chart 1 Jahr

Aktuelle News zur ALCYONE RESOURCES

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBiogen completes acquisition of Alcyone Therapeutics6
FrBiogen Inc.: Biogen Completes Acquisition of Alcyone Therapeutics215CAMBRIDGE, Mass., Nov. 14, 2025Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions...
► Artikel lesen
23.09.Biogen expands portfolio in deal with Alcyone Therapeutics8
ALCYONE RESOURCES Aktie jetzt für 0€ handeln
23.09.IN BRIEF: RTW Biotech lifts NAV on Biogen's $85 million Alcyone deal8
23.09.RTW Biotech Opp. - Biogen to acquire Alcyone Therapeutics5
22.09.Biogen to Acquire Alcyone Therapeutics4
19.09.Biogen buys CNS delivery specialist Alcyone Therapeutics14
19.09.Biogen to acquire Alcyone Therapeutics for $85m6
18.09.Biogen to buy startup Alcyone, eyeing easier delivery of RNA drugs2
18.09.Biogen strikes $85M Alcyone buyout, securing tech for spinal drug delivery2
18.09.Biogen to buy Massachusetts-based Alcyone Therapeutics4
18.09.Biogen To Acquire Alcyone Therapeutics287WESTON (dpa-AFX) - Biogen Inc. (BIIB), a biotechnology company, on Thursday announced that it has entered into a definitive agreement to acquire Massachusetts-based Alcyone Therapeutics for...
► Artikel lesen
18.09.Biogen to acquire Alcyone Therapeutics for $85 million5
18.09.Biogen Inc.: Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates387Biogen to drive end-to-end development and commercialization of ThecaFlex DRx, an investigational implantable device for intrathecal delivery of antisense oligonucleotides (ASOs)ThecaFlex DRx has the...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten